https:\/\/biznes.pap.pl\/espi\/pl\/reports\/view\/2,529369<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the company’s valuation in an M&A process led by an experienced transaction partner, Clairfield Partners LLC. Learn more here: https:\/\/biznes.pap.pl\/espi\/pl\/reports\/view\/2,529369<\/p>\n","protected":false},"author":1,"featured_media":36430,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-37471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\n
Genomtec S.A. intensifies M&A process - Genomtec<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genomtec S.A. intensifies M&A process - Genomtec\" \/>\n<meta property=\"og:description\" content=\"The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the company’s valuation in an M&A process led by an experienced transaction partner, Clairfield Partners LLC. Learn more here: https:\/\/biznes.pap.pl\/espi\/pl\/reports\/view\/2,529369\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/\" \/>\n<meta property=\"og:site_name\" content=\"Genomtec\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-28T19:03:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1900\" \/>\n\t<meta property=\"og:image:height\" content=\"879\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin@genomtec.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genomtec.com\/#website\",\"url\":\"https:\/\/genomtec.com\/\",\"name\":\"Genomtec\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genomtec.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg\",\"contentUrl\":\"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg\",\"width\":1900,\"height\":879},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#webpage\",\"url\":\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/\",\"name\":\"Genomtec S.A. intensifies M&A process - Genomtec\",\"isPartOf\":{\"@id\":\"https:\/\/genomtec.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#primaryimage\"},\"datePublished\":\"2023-02-28T19:03:45+00:00\",\"dateModified\":\"2023-02-28T19:03:45+00:00\",\"author\":{\"@id\":\"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf\"},\"breadcrumb\":{\"@id\":\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Genomtec S.A. intensifies M&A process\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf\",\"name\":\"admin@genomtec.com\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/genomtec.com\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g\",\"caption\":\"admin@genomtec.com\"},\"url\":\"https:\/\/genomtec.com\/en\/author\/admingenomtec-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genomtec S.A. intensifies M&A process - Genomtec","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/","og_locale":"en_US","og_type":"article","og_title":"Genomtec S.A. intensifies M&A process - Genomtec","og_description":"The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the company’s valuation in an M&A process led by an experienced transaction partner, Clairfield Partners LLC. Learn more here: https:\/\/biznes.pap.pl\/espi\/pl\/reports\/view\/2,529369","og_url":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/","og_site_name":"Genomtec","article_published_time":"2023-02-28T19:03:45+00:00","og_image":[{"width":1900,"height":879,"url":"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin@genomtec.com","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/genomtec.com\/#website","url":"https:\/\/genomtec.com\/","name":"Genomtec","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomtec.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#primaryimage","inLanguage":"en-US","url":"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg","contentUrl":"https:\/\/genomtec.com\/wp-content\/uploads\/2022\/05\/news_raport_q1_2022.jpg","width":1900,"height":879},{"@type":"WebPage","@id":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#webpage","url":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/","name":"Genomtec S.A. intensifies M&A process - Genomtec","isPartOf":{"@id":"https:\/\/genomtec.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#primaryimage"},"datePublished":"2023-02-28T19:03:45+00:00","dateModified":"2023-02-28T19:03:45+00:00","author":{"@id":"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf"},"breadcrumb":{"@id":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomtec.com\/en\/2023\/02\/28\/genomtec-sa-intensifies-ma-process\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Genomtec S.A. intensifies M&A process"}]},{"@type":"Person","@id":"https:\/\/genomtec.com\/#\/schema\/person\/1a341d12370a22429e0515e03f637ecf","name":"admin@genomtec.com","image":{"@type":"ImageObject","@id":"https:\/\/genomtec.com\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9e9cc6dab1109231f0b60cf5e90342d08d0039171ecbc1d500786ee9c62be7e7?s=96&d=mm&r=g","caption":"admin@genomtec.com"},"url":"https:\/\/genomtec.com\/en\/author\/admingenomtec-com\/"}]}},"_links":{"self":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/posts\/37471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/comments?post=37471"}],"version-history":[{"count":0,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/posts\/37471\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/media\/36430"}],"wp:attachment":[{"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/media?parent=37471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/categories?post=37471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomtec.com\/en\/wp-json\/wp\/v2\/tags?post=37471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}